Regulation of hematopoiesis through adhesion receptors

Normal steady‐state hematopoiesis takes place in the bone marrow microenvironment. Soluble factors as well as contact interactions between the hematopoietic cells and the marrow microenvironment dictate the fate of hematopoietic stem cells and progenitors. Over the last decade it has become clear that cell‐cell and cell‐extracellular matrix interactions through adhesion receptors play a major role in the hematopoietic process. They are required for the residence of stem cells and progenitors in the marrow, as well as for homing of stem and progenitor cells to the marrow in the setting of stem cell transplantation. Furthermore, adhesion receptors play an important role in regulation of cell behavior, either through direct activation of signal pathways important for cell survival, cell growth, and cell fate decision‐making processes, or by modulating responses to growth factors. Insights in the abnormalities seen in these interactions in diseases of the hematopoietic system will help to develop better therapeutic strategies based on the pathogenesis of these diseases.

[1]  R. Hoffman,et al.  Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes. , 1995, Blood.

[2]  C. Eaves,et al.  Transformation-associated alterations in interactions between pre-B cells and fibronectin. , 1990, Blood.

[3]  B. Longenecker,et al.  Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. , 1992, Blood.

[4]  Shahin Rafii,et al.  Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. , 1999, Blood.

[5]  C. Craddock,et al.  Homing and trafficking of hemopoietic progenitor cells. , 1997, Acta haematologica.

[6]  R. Juliano Cooperation between soluble factors and integrin‐mediated cell anchorage in the control of cell growth and differentiation , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  W. Dalton,et al.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. , 1999, Blood.

[8]  R. Bhatia,et al.  Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors , 1998, Leukemia.

[9]  H. Lodish,et al.  Cytokine receptor signal transduction and the control of hematopoietic cell development. , 1996, Annual review of cell and developmental biology.

[10]  M. T. de la Fuente,et al.  Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. , 1999, Leukemia.

[11]  David A. Williams,et al.  Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. , 1996, Blood.

[12]  J. Parsons,et al.  Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.

[13]  W. Dalton,et al.  Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR) , 2000, Oncogene.

[14]  C. Eaves,et al.  Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. , 1991, Blood.

[15]  F. Giancotti,et al.  Integrin signaling: specificity and control of cell survival and cell cycle progression. , 1997, Current opinion in cell biology.

[16]  D. Williams,et al.  Matrix molecule interactions with hematopoietic stem cells. , 1995, Experimental hematology.

[17]  R. Fuhlbrigge,et al.  A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Hoffman,et al.  Human hematopoietic stem cell adherence to cytokines and matrix molecules. , 1992, The Journal of clinical investigation.

[19]  R. Schofield The stem cell system. , 1983, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  N. Hogg,et al.  Integrin Cross Talk: Activation of Lymphocyte Function-associated Antigen-1 on Human T Cells Alters α4β1- and α5β1-mediated Function , 1997, The Journal of cell biology.

[21]  T. Lebien,et al.  Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. , 1998, Blood.

[22]  C. Verfaillie,et al.  Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin , 1991, The Journal of experimental medicine.

[23]  P. Lansdorp,et al.  Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. , 1995, Blood.

[24]  I. Lemischka Microenvironmental regulation of hematopoietic stem cells , 1997, Stem cells.

[25]  H. Döhner,et al.  Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. , 1999, Blood.

[26]  T. Papayannopoulou,et al.  Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. , 1998, Blood.

[27]  R. Alon,et al.  Selectins, T-cell rolling and inflammation. , 1997, Molecular medicine today.

[28]  T. Springer,et al.  Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis , 1996, The Journal of cell biology.

[29]  David A. Williams,et al.  Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions , 1991, Nature.

[30]  M. Greaves,et al.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.

[31]  M. Wicha,et al.  Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage , 1987, Nature.

[32]  Kenneth M. Yamada,et al.  Integrin functions and signal transduction. , 1997, Advances in Experimental Medicine and Biology.

[33]  F. Behm,et al.  Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. , 1994, Blood.

[34]  A. Zannettino,et al.  Adhesion molecules in haemopoiesis. , 1997, Bailliere's clinical haematology.

[35]  G. Daley,et al.  The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. , 1999, Blood.

[36]  T G Cotter,et al.  BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. , 1994, Blood.

[37]  C. Sassetti,et al.  Identification of Podocalyxin-like Protein as a High Endothelial Venule Ligand for L-selectin: Parallels to CD34 , 1998, The Journal of experimental medicine.

[38]  C. Verfaillie,et al.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. , 1995, The Journal of clinical investigation.

[39]  R. Möhle,et al.  Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. , 1995, Experimental hematology.

[40]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[41]  J. Burthem,et al.  Integrin function in chronic lymphocytic leukemia. , 1996, Blood.

[42]  Paul J. Williams,et al.  Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity , 2000 .

[43]  S. Dedhar,et al.  Protein kinase mediators of integrin signal transduction , 1997, Journal of Molecular Medicine.

[44]  S. Ghaffari,et al.  Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. , 1996, Leukemia.

[45]  D. Catovsky,et al.  Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias , 1997, Leukemia.

[46]  F. Sánchez‐Madrid,et al.  CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. , 1998, Blood.

[47]  E. Paietta Adhesion molecules in acute myeloid leukemia☆ , 1996, Leukemia Research.

[48]  T. Springer,et al.  Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. , 1987, Annual review of medicine.

[49]  J. Dick,et al.  A newly discovered class of human hematopoietic cells with SCID-repopulating activity , 1998, Nature Medicine.

[50]  Richard O. Hynes,et al.  Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1 , 1998, The Journal of experimental medicine.

[51]  D. McMillin,et al.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. , 1998, The Journal of clinical investigation.

[52]  P. V. van Hennik,et al.  Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. , 1999, Blood.

[53]  F. Schriever,et al.  Differential adhesion pattern of B cell chronic lymphocytic leukemia cells , 1998, Leukemia.

[54]  T. Witzig The role of adhesion receptors in the pathogenesis of multiple myeloma. , 1999, Hematology/oncology clinics of North America.

[55]  P. Murphy,et al.  Chemokine receptors and molecular mimicry. , 1994, Immunology today.

[56]  M. Vadas,et al.  Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins , 1995, The Journal of experimental medicine.

[57]  S. Rodenhuis,et al.  Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. , 1995, Blood.

[58]  J. Parsons,et al.  Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. , 1995, Molecular biology of the cell.

[59]  A. Mastrangelo,et al.  Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[60]  A. Kimura,et al.  L-selectin expression in CD34 positive cells in chronic myeloid leukemia. , 1998, Leukemia & lymphoma.

[61]  H. Broxmeyer,et al.  Hematopoietic defects in mice lacking the sialomucin CD34. , 1996, Blood.

[62]  Y. Yazaki,et al.  Matrix/Integrin Interaction Activates the Mitogen-activated Protein Kinase, p44 and p42(*) , 1995, The Journal of Biological Chemistry.

[63]  C. Verfaillie,et al.  Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors? , 1997, Acta haematologica.

[64]  M. Greaves,et al.  Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment , 1987, Nature.

[65]  T. Libermann,et al.  Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. , 1996, Blood.

[66]  C. Verfaillie,et al.  Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. , 1994, Blood.

[67]  R. Bhatia,et al.  Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. , 1999, Experimental hematology.

[68]  B. Zehnbauer,et al.  Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. , 1994, Blood.

[69]  M. Andreeff,et al.  Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[70]  K. McIntyre,et al.  Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. , 1994, Immunity.

[71]  E. Ruoslahti,et al.  Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases , 1996, Molecular and cellular biology.

[72]  R. Hoffman,et al.  A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hematopoietic progenitor cells but not stem cells. , 1996, Blood.

[73]  C. Verfaillie,et al.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. , 1994, The Journal of clinical investigation.

[74]  T. Dexter,et al.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.

[75]  C. Verfaillie,et al.  Monoclonal antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. , 1997, Experimental hematology.

[76]  R. Hynes,et al.  Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[77]  L. Bendall,et al.  Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. , 1993, Blood.

[78]  S. Rafii,et al.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.

[79]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[80]  E. Butcher,et al.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.

[81]  I. Mckenzie,et al.  Mucins: Structure, function, and associations with malignancy , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[82]  B. Druker,et al.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. , 2000, The Journal of clinical investigation.

[83]  C. Hardy The Homing of Hematopoietic Stem Cells to the Bone Marrow , 1995, The American journal of the medical sciences.

[84]  B. Sela [Selectins: vascular adhesion molecules]. , 2000, Harefuah.

[85]  J. Griffin,et al.  Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. , 1996, The Journal of clinical investigation.

[86]  R. Soutar,et al.  Expression of adhesion molecules in malignant plasma cells in multiple myeloma: comparison with normal plasma cells and functional significance. , 1997, Blood reviews.

[87]  C. Verfaillie,et al.  Role of bone marrow matrix in normal and abnormal hematopoiesis. , 1994, Critical reviews in oncology/hematology.

[88]  J. Greenberger,et al.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. , 1992, The Journal of clinical investigation.

[89]  M. Greaves,et al.  The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  C. Verfaillie,et al.  Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow. , 2000, Experimental hematology.

[91]  P. Bates,et al.  PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. , 1995, Leukemia & lymphoma.

[92]  C. Figdor,et al.  High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. , 1999, Blood.

[93]  J. Guan,et al.  Differential Regulation of Pyk2 and Focal Adhesion Kinase (FAK) , 1998, The Journal of Biological Chemistry.

[94]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[95]  F. Prósper,et al.  Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. , 2000, Blood.

[96]  A. Zannettino,et al.  PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. , 1999, Immunity.

[97]  A. García-Pardo,et al.  Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax , 1999, Leukemia.

[98]  R. Fässler,et al.  Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. , 2000, Immunity.

[99]  D. Wagner P-selectin knockout: a mouse model for various human diseases. , 2007, Ciba Foundation symposium.

[100]  A. Beaudet,et al.  Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[101]  C. Verfaillie,et al.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. , 1992, The Journal of clinical investigation.

[102]  R. Salgia,et al.  Differential Signaling after β1 Integrin Ligation Is Mediated Through Binding of CRKL to p120 CBL and p110 HEF1 * , 1997, The Journal of Biological Chemistry.

[103]  S. Rafii,et al.  Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. , 2000, The Journal of clinical investigation.

[104]  J. Guan,et al.  Focal adhesion kinase in integrin signaling. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[105]  R L Juliano,et al.  Integrin signaling and cell growth control. , 1998, Current opinion in cell biology.

[106]  C. Verfaillie,et al.  Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. , 1996, Blood.

[107]  Y. Shimizu,et al.  Regulating integrin-mediated adhesion: one more function for PI 3-kinase? , 1996, Immunology today.

[108]  T. Papayannopoulou,et al.  Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm. , 2000, Seminars in hematology.

[109]  C. Craddock,et al.  The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  A. Zannettino,et al.  CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. , 1998, Blood.

[111]  C. Figdor,et al.  The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. , 2000, Seminars in hematology.

[112]  A. Zannettino,et al.  CD164 Monoclonal Antibodies That Block Hemopoietic Progenitor Cell Adhesion and Proliferation Interact with the First Mucin Domain of the CD164 Receptor1 , 2000, The Journal of Immunology.

[113]  E. Hirsch,et al.  Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins , 1996, Nature.

[114]  C. Verfaillie,et al.  Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. , 1992, Blood.

[115]  R. Ganju,et al.  The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways* , 1998, The Journal of Biological Chemistry.

[116]  L. Lasky,et al.  The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. , 1995, Blood.

[117]  A. Zannettino,et al.  Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. , 2000, Blood.

[118]  C. Verfaillie,et al.  Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. , 1996, Blood.

[119]  T. Yoneda,et al.  Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. , 2000, Blood.

[120]  C. Verfaillie,et al.  Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. , 1996, Leukemia.

[121]  I. Kato,et al.  Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. , 1998, Blood.

[122]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. Fackler,et al.  Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. , 1995, Blood.

[124]  C. Verfaillie,et al.  Activation of β1 integrins on CML progenitors reveals cooperation between β1 integrins and CD44 in the regulation of adhesion and proliferation , 1997, Leukemia.

[125]  L. Gibson,et al.  Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. , 2000, Blood.

[126]  K. Ley,et al.  Gene-targeted mice reveal importance of L-selectin-dependent rolling for neutrophil adhesion. , 1998, American journal of physiology. Heart and circulatory physiology.

[127]  D. Wagner,et al.  Insights into Selectin Function from Knockout Mice , 1997, Thrombosis and Haemostasis.

[128]  H. Kantarjian,et al.  Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy. , 1998, Hematology/oncology clinics of North America.

[129]  A. Varki,et al.  Perspectives Series: Cell Adhesion in Vascular Biology Selectin Ligands: Will the Real Ones Please Stand Up? , 2022 .

[130]  R. Sackstein,et al.  A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity. , 1997, Blood.

[131]  R. Sackstein,et al.  A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. , 2000, Blood.

[132]  T. Hunter,et al.  Pyk2 and Src‐family protein‐tyrosine kinases compensate for the loss of FAK in fibronectin‐stimulated signaling events but Pyk2 does not fully function to enhance FAK− cell migration , 1998, The EMBO journal.

[133]  K. Anderson,et al.  Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. , 1997, Hematology/oncology clinics of North America.

[134]  C. Figdor,et al.  Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. , 1998, Blood.

[135]  L. Lagneaux,et al.  Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. , 1998, Blood.